Skip to main content

Oral combination medications

Journal articles and book chapters

05-18-2018 | Type 2 diabetes | Review | Article

Combination glucose-lowering therapy plans in T2DM: Case-based considerations

Blonde L, Dipp S, Cadena D. Adv Ther 2018. doi: 10.1007/s12325-018-0694-0

04-05-2018 | Oral combination medications | Review | Article

Combination treatment of SGLT2 inhibitors and GLP-1 receptor agonists: Symbiotic effects on metabolism and cardiorenal risk

Goncalves E, Bell DSH. Diabetes Ther 2018; 9: 919–926. doi: 10.1007/s13300-018-0420-6

03-23-2018 | Oral combination medications | Article

SGLT2 inhibitor plus DPP‐4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta‐analysis

Li D et al. Diabetes Obes Metab 2018; Advance online publication. doi: 10.1111/dom.13294

02-03-2017 | Medications | Review | Article

Early combination therapy with oral glucose-lowering agents in type 2 diabetes

Bianchi C et al. Drugs 2017; 77: 247–264. doi: 10.1007/s40265-017-0694-4

11-10-2016 | Type 2 diabetes | Review | Article

Clinical pharmacokinetics and pharmacodynamics of antihyperglycemic medications in children and adolescents with type 2 diabetes mellitus

Akhlaghi F et al. Clin Pharmacokinet 2017; 56: 561–571. doi:10.1007/s40262-016-0472-6

10-17-2016 | Gestational diabetes | Review | Article

Pharmacological management of gestational diabetes mellitus

Bergel R et al. Curr Diab Rep 2016; 16: 118. doi: 10.1007/s11892-016-0802-y